EGFR and cancer: Supplementary Table S1 lists the characteristic biological processes enriched by 51 miRNAs that were differentially expressed according to EGFR mutation status. The top 30 biological pathways included the “Hippo signaling pathway (hsa04390)” (p = 2.38E–08), “pathways in cancer (hsa05200)” (p = 4.33E–05), and “non-small-cell lung cancer (hsa05223)” (p = 3.75E–03), as shown in Table 3. “Pathways in cancer” was enriched in miRNAs, which included the five abovementioned concordant miRNAs [38].